Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check7 days agoChange DetectedThe page history now displays Revision: v3.6.5, replacing Revision: v3.6.4. This reflects a new software release applied to the page.SummaryDifference0.1%

- Check14 days agoChange DetectedNew entries were added on 2026-07-30 for Study Status and Contacts/Locations, and an additional item '27' was added on 2026-07-29. An entry dated 2026-07-01 was removed.SummaryDifference0.4%

- Check21 days agoChange DetectedThe Record History now shows a new revision (v3.6.4) replacing the previous v3.6.3, signaling an updated version of the page.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe study history gains a Contacts/Locations section and an updated Study Status, corresponding to revision v3.6.3 released on 2026-07-01.SummaryDifference0.5%

- Check50 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, reflecting a software version update for the study history page.SummaryDifference0.1%

- Check64 days agoChange DetectedRecruitment status was updated to 'No longer looking for participants,' indicating enrollment closure. A new revision tag 'Revision: v3.6.0' was added to the history, replacing the previous 'Revision: v3.5.5'.SummaryDifference0.3%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.